Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,628 | 8,191 | 10,799 | 12,603 | 427 |
| TOTAL | $11,026 | $9,044 | $11,624 | $13,686 | $1,137 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $11,026 | $9,044 | $11,624 | $13,686 | $1,137 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 175 |
| Accounts payable and accrued liabilities | 609 | 662 | 515 | 770 | 881 |
| Accrued Expenses | 758 | 529 | 1,002 | 425 | 587 |
| TOTAL | $1,367 | $1,192 | $1,517 | $1,195 | $1,643 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,367 | $1,192 | $1,517 | $1,195 | $1,643 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 4 | 3 | 3 | 3 |
| Common Shares | 1 | 1 | 1 | 1 | 0 |
| Retained earnings | -41,499 | -38,768 | -35,982 | -33,429 | -31,717 |
| TOTAL | $9,660 | $7,853 | $10,107 | $12,491 | $-506 |
| Total Liabilities And Equity | $11,027 | $9,044 | $11,624 | $13,686 | $1,137 |